BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37713200)

  • 1. Travel Time and Distance and Participation in Precision Oncology Trials at the National Cancer Center Hospital.
    Uehara Y; Koyama T; Katsuya Y; Sato J; Sudo K; Kondo S; Yoshida T; Shoji H; Shimoi T; Yonemori K; Yamamoto N
    JAMA Netw Open; 2023 Sep; 6(9):e2333188. PubMed ID: 37713200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Collaboration Between a Health Plan, Oncology Practice, and Comprehensive Genomic Profiling Company from the Payer Perspective.
    Reitsma M; Fox J; Borre PV; Cavanaugh M; Chudnovsky Y; Erlich RL; Gribbin TE; Anhorn R
    J Manag Care Spec Pharm; 2019 May; 25(5):601-611. PubMed ID: 30632889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Remote Technology Use and Other Decentralization Tools With Patient Likelihood to Enroll in Cancer Clinical Trials.
    Adams DV; Long S; Fleury ME
    JAMA Netw Open; 2022 Jul; 5(7):e2220053. PubMed ID: 35788672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical Trials.
    Borno HT; Zhang L; Siegel A; Chang E; Ryan CJ
    Oncologist; 2018 Oct; 23(10):1242-1249. PubMed ID: 29700209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From 2017 to 2022.
    Pittell H; Calip GS; Pierre A; Ryals CA; Altomare I; Royce TJ; Guadamuz JS
    JAMA Netw Open; 2023 Jul; 6(7):e2322515. PubMed ID: 37477920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in phase 1 cancer clinical trial enrollment.
    Perni S; Moy B; Nipp RD
    Cancer; 2021 Dec; 127(23):4464-4469. PubMed ID: 34379799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.
    Singal G; Miller PG; Agarwala V; Li G; Kaushik G; Backenroth D; Gossai A; Frampton GM; Torres AZ; Lehnert EM; Bourque D; O'Connell C; Bowser B; Caron T; Baydur E; Seidl-Rathkopf K; Ivanov I; Alpha-Cobb G; Guria A; He J; Frank S; Nunnally AC; Bailey M; Jaskiw A; Feuchtbaum D; Nussbaum N; Abernethy AP; Miller VA
    JAMA; 2019 Apr; 321(14):1391-1399. PubMed ID: 30964529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy Opportunities.
    Matsubara J; Mukai K; Kondo T; Yoshioka M; Kage H; Oda K; Kudo R; Ikeda S; Ebi H; Muro K; Hayashi R; Tokudome N; Yamamoto N; Muto M
    JAMA Netw Open; 2023 Jul; 6(7):e2323336. PubMed ID: 37459099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.
    Stockley TL; Oza AM; Berman HK; Leighl NB; Knox JJ; Shepherd FA; Chen EX; Krzyzanowska MK; Dhani N; Joshua AM; Tsao MS; Serra S; Clarke B; Roehrl MH; Zhang T; Sukhai MA; Califaretti N; Trinkaus M; Shaw P; van der Kwast T; Wang L; Virtanen C; Kim RH; Razak AR; Hansen AR; Yu C; Pugh TJ; Kamel-Reid S; Siu LL; Bedard PL
    Genome Med; 2016 Oct; 8(1):109. PubMed ID: 27782854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Referrals to a Phase I Clinic and Trial Enrollment in the Molecular Screening Era.
    Tan T; Rheaume M; Wang L; Chow H; Spreafico A; Hansen AR; Razak ARA; Siu LL; Bedard PL
    Oncologist; 2019 Jul; 24(7):e518-e525. PubMed ID: 30833487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity Intervention.
    Nipp RD; Lee H; Gorton E; Lichtenstein M; Kuchukhidze S; Park E; Chabner BA; Moy B
    Oncologist; 2019 Aug; 24(8):1048-1055. PubMed ID: 30988039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronological improvement in precision oncology implementation in Japan.
    Sunami K; Naito Y; Komine K; Amano T; Ennishi D; Imai M; Kage H; Kanai M; Kenmotsu H; Koyama T; Maeda T; Morita S; Sakai D; Kohsaka S; Tsuchihara K; Saigusa Y; Yoshino T
    Cancer Sci; 2022 Nov; 113(11):3995-4000. PubMed ID: 35976133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Hypothetical Centralization of Revision THA and TKA Exacerbate Existing Geographic or Demographic Disparities in Access to Care by Increased Patient Travel Distances or Times? A Large-database Study.
    Ramirez G; Myers TG; Thirukumaran CP; Ricciardi BF
    Clin Orthop Relat Res; 2022 Jun; 480(6):1033-1045. PubMed ID: 34870619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers.
    Hagio K; Kikuchi J; Takada K; Tanabe H; Sugiyama M; Ohhara Y; Amano T; Yuki S; Komatsu Y; Osawa T; Hatanaka KC; Hatanaka Y; Mitamura T; Yabe I; Matsuno Y; Manabe A; Sakurai A; Ishiguro A; Takahashi M; Yokouchi H; Naruse H; Mizukami Y; Dosaka-Akita H; Kinoshita I
    Cancer Sci; 2023 Aug; 114(8):3385-3395. PubMed ID: 37208840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
    Murthy VH; Krumholz HM; Gross CP
    JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budget impact analysis of comprehensive genomic profiling in patients with advanced non-small cell lung cancer.
    Signorovitch J; Zhou Z; Ryan J; Anhorn R; Chawla A
    J Med Econ; 2019 Feb; 22(2):140-150. PubMed ID: 30430885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic and Health Behavior Factors Associated With Clinical Trial Invitation and Participation in the United States.
    Williams CP; Senft Everson N; Shelburne N; Norton WE
    JAMA Netw Open; 2021 Sep; 4(9):e2127792. PubMed ID: 34586365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans.
    Goldberg DS; French B; Forde KA; Groeneveld PW; Bittermann T; Backus L; Halpern SD; Kaplan DE
    JAMA; 2014 Mar; 311(12):1234-43. PubMed ID: 24668105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation.
    Unger JM; Hershman DL; Fleury ME; Vaidya R
    JAMA Oncol; 2019 Mar; 5(3):326-333. PubMed ID: 30629092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.